Below are the most recent publications written about "Urokinase-Type Plasminogen Activator" by people in Profiles.
-
Koenigs A, Hammerschmidt C, Jutras BL, Pogoryelov D, Barthel D, Skerka C, Kugelstadt D, Wallich R, Stevenson B, Zipfel PF, Kraiczy P. BBA70 of Borrelia burgdorferi is a novel plasminogen-binding protein. J Biol Chem. 2013 Aug 30; 288(35):25229-25243.
-
Hawse WF, Champion MM, Joyce MV, Hellman LM, Hossain M, Ryan V, Pierce BG, Weng Z, Baker BM. Cutting edge: Evidence for a dynamically driven T cell signaling mechanism. J Immunol. 2012 Jun 15; 188(12):5819-23.
-
Yoo AJ, Hakimelahi R, Rost NS, Schaefer PW, Hirsch JA, Gonz?lez RG, Rabinov JD. Diffusion weighted imaging reversibility in the brainstem following successful recanalization of acute basilar artery occlusion. J Neurointerv Surg. 2010 Sep; 2(3):195-7.
-
Goddeau RP, Caplan LR, Alhazzani AA. Intraparenchymal hemorrhage in a patient with osteogenesis imperfecta and plasminogen activator inhibitor-1 deficiency. Arch Neurol. 2010 Feb; 67(2):236-8.
-
Kulcs?r Z, Marosfoi M, Berentei Z, Szikora I. Continuous thrombolysis and repeated thrombectomy with the Penumbra System in a child with hemorrhagic sinus thrombosis: technical note. Acta Neurochir (Wien). 2010 May; 152(5):911-6.
-
Fritz V, No?l D, Bouquet C, Opolon P, Voide R, Apparailly F, Louis-Plence P, Bouffi C, Drissi H, Xie C, Perricaudet M, M?ller R, Schwarz E, Jorgensen C. Antitumoral activity and osteogenic potential of mesenchymal stem cells expressing the urokinase-type plasminogen antagonist amino-terminal fragment in a murine model of osteolytic tumor. Stem Cells. 2008 Nov; 26(11):2981-90.
-
Beaulieu LM, Whitley BR, Wiesner TF, Rehault SM, Palmieri D, Elkahloun AG, Church FC. Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycle. Bioessays. 2007 Oct; 29(10):1029-38.
-
Whitley BR, Beaulieu LM, Carter JC, Church FC. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells. Gynecol Oncol. 2007 Feb; 104(2):470-9.
-
Hall CL, Tsan R, Mugnai G, Mazar A, Radinsky R, Pettaway CA. Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA). Prostate. 2004 May 01; 59(2):167-76.
-
Gates J, Hartnell GG. When urokinase was gone: commentary on another year of thrombolysis without urokinase. J Vasc Interv Radiol. 2004 Jan; 15(1 Pt 1):1-5.